ConductScience.org, home

Paper33809702

A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.

Blum K and 13 others. J Pers Med, 2021. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Papers, record 33809702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33809702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
PubMed
Journal
J Pers Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2021-04-13
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blum KKennethhttps://orcid.org/0000-0001-6727-803X
2Kazmi SShan
3Modestino EJEdward Jhttps://orcid.org/0000-0001-7611-5144
4Downs BWBill William
5Bagchi DDebasis
6Baron DDavid
7McLaughlin TThomas
8Green RRichard
9Jalali RRehan
10Thanos PKPanayotis K
11Elman IIgor
12Badgaiyan RDRajendra Dhttps://orcid.org/0000-0001-5586-5114
13Bowirrat AAbdalla
14Gold MSMark S

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I01 CX000479/CX/CSRD VA/United StatesVAUnited StatesI01CX000479PubMedNIH RePORTER
R41 MD012318/MD/NIMHD NIH HHS/United StatesHealth and Health Services Research FundR41MD012318PubMedNIH RePORTER

Download CSV of grants

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121084795
Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Postgrad Med2010https://conductscience.org/library/papers/21084795PubMed
28632351Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.J Pharmacol Exp Ther1996https://conductscience.org/library/papers/8632351PubMed
328274137Post-traumatic stress symptoms in pathological gambling: Potential evidence of anti-reward processes.J Behav Addict2017https://conductscience.org/library/papers/28274137PubMed
431820688Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.Curr Pharm Biotechnol2020https://conductscience.org/library/papers/31820688PubMed
523926462Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.J Addict Res Ther2012https://conductscience.org/library/papers/23926462PubMed
69160798Putative oxidative metabolites of 1-methyl-6-hydroxy-1,2,3,4-tetrahydro-beta-carboline of potential relevance to the addictive and neurodegenerative consequences of ethanol abuse.Alcohol1997https://conductscience.org/library/papers/9160798PubMed
73067616Mechanism and regulation of ethanol elimination in humans: intermolecular hydrogen transfer and oxidoreduction in vivo.Alcohol Clin Exp Res1988https://conductscience.org/library/papers/3067616PubMed
826450814Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI.Neuropsychopharmacology2016https://conductscience.org/library/papers/26450814PubMed
928951609Rehabilitating the addicted brain with transcranial magnetic stimulation.Nat Rev Neurosci2017https://conductscience.org/library/papers/28951609PubMed
1031833150Cannabis use, depression and self-harm: phenotypic and genetic relationships.Addiction2020https://conductscience.org/library/papers/31833150PubMed
1130348770Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30348770PubMed
1231093318Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood.Oxid Med Cell Longev2019https://conductscience.org/library/papers/31093318PubMed
1326724386Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly.Am J Pathol2016https://conductscience.org/library/papers/26724386PubMed
1423827972Pain and suicidality: insights from reward and addiction neuroscience.Prog Neurobiol2013https://conductscience.org/library/papers/23827972PubMed
1532609628Co-occurrences of substance use and other potentially addictive behaviors: Epidemiological results from the Psychological and Genetic Factors of the Addictive Behaviors (PGA) Study.J Behav Addict2020https://conductscience.org/library/papers/32609628PubMed
1629379966Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis.J Am Osteopath Assoc2018https://conductscience.org/library/papers/29379966PubMed
1732432229Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency.J Addict Sci2020https://conductscience.org/library/papers/32432229PubMed
1830197787"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic.J Syst Integr Neurosci2017https://conductscience.org/library/papers/30197787PubMed
1929512887Opioid and nondopamine reward circuitry and state-dependent mechanisms.Ann N Y Acad Sci2019https://conductscience.org/library/papers/29512887PubMed
2032934823Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual.J Syst Integr Neurosci2020https://conductscience.org/library/papers/32934823PubMed

See all 110 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42072408A Personalized Medicine Approach: Psychosocial and Genetic Risk Assessments Predictors of Bariatric Surgery Outcomes After 3 Years.Biomedicines2026https://conductscience.org/library/papers/42072408PubMed
41249063Billions Spent, Few Saved: Rethinking National Institutes of Health HEAL Initiative in Light of Dopaminergic Alternatives to the Opioid Trap.Int J Spine Surg2025https://conductscience.org/library/papers/41249063PubMed
40933508Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and Present.J Addict Psychiatry2025https://conductscience.org/library/papers/40933508PubMed
40742457
A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects.
Cell Mol Neurobiol2025https://conductscience.org/library/papers/40742457PubMed
40247807
A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era.
Curr Pharm Biotechnol2025https://conductscience.org/library/papers/40247807PubMed
39507617
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies.
Open J Immunol2024https://conductscience.org/library/papers/39507617PubMed
39411118A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD).Psychol Res Behav Manag2024https://conductscience.org/library/papers/39411118PubMed
38765881Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.J Addict Psychiatry2024https://conductscience.org/library/papers/38765881PubMed
38561465Differential DNA methylation in iPSC-derived dopaminergic neurons: a step forward on the role of SNORD116 microdeletion in the pathophysiology of addictive behavior in Prader-Willi syndrome.Mol Psychiatry2024https://conductscience.org/library/papers/38561465PubMed
37885438
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.
Med Res Arch2023https://conductscience.org/library/papers/37885438PubMed
37599869Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence.Front Psychiatry2023https://conductscience.org/library/papers/37599869PubMed
36618806Offering a putative neurobiological "dopamine homeostatic" solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of "precision behavioral management".Ann Transl Med2022https://conductscience.org/library/papers/36618806PubMed
36579510Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.J Pers Med2022https://conductscience.org/library/papers/36579510PubMed
36556236
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.
J Pers Med2022https://conductscience.org/library/papers/36556236PubMed
36143203
DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of "Dopamine Homeostasis" in the Face of the Opioid Crisis.
J Pers Med2022https://conductscience.org/library/papers/36143203PubMed
35954830Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35954830PubMed
35681980Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?Int J Environ Res Public Health2022https://conductscience.org/library/papers/35681980PubMed
35096419Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD).J Syst Integr Neurosci2020https://conductscience.org/library/papers/35096419PubMed
35010811
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.
Int J Environ Res Public Health2022https://conductscience.org/library/papers/35010811PubMed
34770047Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34770047PubMed

See all 21 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33809702

GET https://conductscience.org/api/papers/v1/33809702/references?page=2